Defining the role of albumin infusion in cirrhosis-associated hyponatremia.
The presence of negatively charged, impermeant proteins in the plasma space alters the distribution of diffusible ions in the plasma and interstitial fluid (ISF) compartments to preserve electroneutrality and is known as Gibbs-Donnan equilibrium. In patients with hypoalbuminemia due to underlying cirrhosis, the decrease in the plasma water albumin concentration ([Alb-]pw) would be expected to result in a decrease in the plasma water sodium concentration ([Na+]pw) due to an alteration in the distribution of Na+ between the plasma and ISF. In addition, cirrhosis-associated hyponatremia may be due to the renal diluting defect resulting from the intravascular volume depletion due to gastrointestinal losses and overdiuresis and/or decreased effective circulatory volume secondary to splanchnic vasodilatation. Therefore, albumin infusion may result in correction of the hyponatremia in cirrhotic patients either by modulating the Gibbs-Donnan effect due to hypoalbuminemia or by restoring intravascular volume in patients with intravascular volume depletion due to gastrointestinal losses and overdiuresis. However, the differential role of albumin infusion in modulating the [Na+]pw in these patients has not previously been analyzed quantitatively. In the present study, we developed an in vitro assay system to examine for the first time the quantitative effect of changes in albumin concentration on the distribution of Na+ between two compartments separated by a membrane that allows the free diffusion of Na+. Our findings demonstrated that changes in [Alb-]pw are linearly related to changes in [Na+]pw as predicted by Gibbs-Donnan equilibrium. However, based on our findings, we predict that the improvement in cirrhosis-associated hyponatremia due to intravascular volume depletion results predominantly from the restoration of intravascular volume rather than alterations in Gibbs-Donnan equilibrium.
Department of Medicine, University of California Los Angeles, Los Angeles, California; mtnguyen@mednet.ucla.edu.
Minhtri K
MK
Nguyen
Department of Medicine, University of California Los Angeles, Los Angeles, California;
Vahram
V
Ornekian
Department of Medicine, University of California Los Angeles, Los Angeles, California;
Liyo
L
Kao
Department of Pathology & Laboratory Medicine, University of California Los Angeles, Los Angeles, California; and.
Anthony W
AW
Butch
Department of Medicine, University of California Los Angeles, Los Angeles, California; Brain Research Institute, University of California Los Angeles, Los Angeles, California.
Ira
I
Kurtz
D000418:Albumins / Q000008:administration & dosage* / Q000378:metabolism; D004058:Diffusion; D045604:Extracellular Fluid / Q000378:metabolism*; D006801:Humans; D034141:Hypoalbuminemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D007010:Hyponatremia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D007263:Infusions, Parenteral; D016014:Linear Models; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications*; D008954:Models, Biological; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000378:metabolism; D010953:Plasma Volume; D012709:Serum Albumin / Q000378:metabolism; D012964:Sodium / Q000097:blood / Q000378:metabolism*
D000418:Albumins; D010952:Plasma Substitutes; D012709:Serum Albumin; D012964:Sodium
Gibbs-Donnan equilibrium; dysnatremias; hypoalbuminemia